Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin Switch Therapy After Intravenous Carbapenem for Acute Pyelonephritis Caused by Third-Generation Cephalosporin-Resistant Pathogens: Pilot RCT
TCTR20181202002Phase 4Terminated
- Sponsor
- Thai Meiji Pharmaceutical
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of prulifloxacin in acute pyelonephritis, sponsored by Thai Meiji Pharmaceutical. Started Aug 2015; status: terminated.
02
Drugs
prulifloxacin
03
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on TCTR20181202002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181202002.